Importantly, FGF9 has high affinity for its receptor, FGFR3, and, as discussed later in this review, over-activating mutations in FGFR3 in humans and mice cause achondroplasia and midfacial hypoplasia. The gene discussed is FGFR3; the disease is achondroplasia.